SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gail J Roboz, Pau Montesinos, Dominik Selleslag, Andrew Wei, Jun-Ho Jang, Jose Falantes, Maria T Voso, Hamid Sayar, Kimmo Porkka, Paula Marlton, Antonio Almeida, Sanjay Mohan, Farhad Ravandi, Guillermo Garcia-Manero, Barry Skikne, Hagop Kantarjian, Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia, Future Oncology, 2016, 12, 3, 293

    CrossRef

  2. 2
    Courtney D. DiNardo, Guillermo Garcia-Manero, Sherry Pierce, Aziz Nazha, Carlos Bueso-Ramos, Elias Jabbour, Farhad Ravandi, Jorge Cortes, Hagop Kantarjian, Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), American Journal of Hematology, 2016, 91, 2
  3. 3
    Armin Rashidi, Maryam Ebadi, Graham A. Colditz, John F. DiPersio, Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis, Biology of Blood and Marrow Transplantation, 2016, 22, 4, 651

    CrossRef

  4. 4
    Jose J.G. Marin, Oscar Briz, Gabriela Rodríguez-Macias, José L. Díez-Martín, Rocio I.R. Macias, Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia, Blood Reviews, 2016, 30, 1, 55

    CrossRef

  5. 5
    Ying-Gui Yang, Ita Novita Sari, Mohammad Farid Zia, Sung Ryul Lee, Su Jung Song, Hyog Young Kwon, Tetraspanins: Spanning from solid tumors to hematologic malignancies, Experimental Hematology, 2016, 44, 5, 322

    CrossRef

  6. 6
    Glenda J. Dickson, Sophia Bustraan, Robert K. Hills, Akbar Ali, Anthony H. Goldstone, Alan K. Burnett, David C. Linch, Rosemary E. Gale, The value of molecular stratification for CEBPADM and NPM1MUTFLT3WT genotypes in older patients with acute myeloid leukaemia, British Journal of Haematology, 2016, 172, 4
  7. 7
    A G Dinmohamed, O Visser, Y van Norden, N M A Blijlevens, J J Cornelissen, G A Huls, P C Huijgens, P Sonneveld, A A van de Loosdrecht, G J Ossenkoppele, B Löwenberg, M Jongen-Lavrencic, Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012, Leukemia, 2016, 30, 1, 24

    CrossRef

  8. 8
    S S Kenderian, M Ruella, O Shestova, M Klichinsky, V Aikawa, J J D Morrissette, J Scholler, D Song, D L Porter, M Carroll, C H June, S Gill, CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia, Leukemia, 2015, 29, 8, 1637

    CrossRef

  9. 9
    Heidi D. Klepin, Elderly Acute Myeloid Leukemia: Assessing Risk, Current Hematologic Malignancy Reports, 2015, 10, 2, 118

    CrossRef

  10. 10
    Laura Finn, Lisa Sproat, Michael G. Heckman, Liuyan Jiang, Nancy N. Diehl, Rhett Ketterling, Raoul Tibes, Ricardo Valdez, James Foran, Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy, Cancer Epidemiology, 2015, 39, 6, 1084

    CrossRef

  11. 11
    G. Ossenkoppele, B. Lowenberg, How I treat the older patient with acute myeloid leukemia, Blood, 2015, 125, 5, 767

    CrossRef

  12. 12
    Mary-Elizabeth M. Percival, Li Tao, Bruno C. Medeiros, Christina A. Clarke, Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis, Cancer, 2015, 121, 12
  13. 13
    F. Buccisano, L. Maurillo, A. Piciocchi, M. I. Del Principe, C. Sarlo, M. Cefalo, C. Ditto, A. Di Veroli, G. De Santis, M. Irno Consalvo, D. Fraboni, P. Panetta, P. Palomba, C. Attrotto, G. Del Poeta, G. Sconocchia, F. Lo-Coco, S. Amadori, A. Venditti, Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients, Annals of Hematology, 2015, 94, 8, 1319

    CrossRef

  14. 14
    Catherine C. Coombs, Martin S. Tallman, Ross L. Levine, Molecular therapy for acute myeloid leukaemia, Nature Reviews Clinical Oncology, 2015, 13, 5, 305

    CrossRef

  15. 15
    Laura C. Michaelis, Harry P. Erba, Recent developments in the treatment of older individuals with acute myeloid leukemia, Current Opinion in Hematology, 2015, 22, 2, 108

    CrossRef

  16. 16
    Talha Badar, Farhad Ravandi, Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome, Clinical Lymphoma Myeloma and Leukemia, 2015, 15, S104

    CrossRef

  17. 17
    Benedito A Carneiro, Jessica K Altman, Jason B Kaplan, Gert Ossenkoppele, Ronan Swords, Leonidas C Platanias, Francis J Giles, Targeted therapy of acute myeloid leukemia, Expert Review of Anticancer Therapy, 2015, 15, 4, 399

    CrossRef

  18. 18
    Latha Ramireddy, Chien-Yu Lin, Su-Ching Liu, Wan-Yu Lo, Rouh-Mei Hu, Yi-Chin Peng, Ching-Tien Peng, Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan, Cell Biochemistry and Biophysics, 2014, 70, 2, 1159

    CrossRef

  19. 19
    Hai-ying Fu, Dan-sen Wu, Hua-rong Zhou, Jian-zhen Shen, CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients, Hematology, 2014, 19, 6, 329

    CrossRef

  20. 20
    Santhosh K. Sadashiv, Christie Hilton, Cyrus Khan, James M. Rossetti, Heather L. Benjamin, Salman Fazal, Entezam Sahovic, Richard K. Shadduck, John Lister, Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia, Cancer Medicine, 2014, 3, 6
  21. 21
    H. D. Klepin, Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia, Hematology, 2014, 2014, 1, 8

    CrossRef

  22. 22
    Binay Kumar Shah, Krishna Bilas Ghimire, Improved survival among older acute myeloid leukemia patients – a population-based study, Acta Oncologica, 2014, 53, 7, 935

    CrossRef

  23. 23
    Andrew M. Brunner, Traci M. Blonquist, Hossein Sadrzadeh, Ashley M. Perry, Eyal C. Attar, Philip C. Amrein, Karen K. Ballen, Yi-Bin Chen, Donna S. Neuberg, Amir T. Fathi, Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis, Leukemia Research, 2014, 38, 7, 773

    CrossRef

  24. 24
    Felicetto Ferrara, Piera Angelillo, Antonella Carbone, Cira Riccardi, Is chemotherapy really the best option in older adults with acute myeloid leukemia?, International Journal of Hematologic Oncology, 2013, 2, 5, 355

    CrossRef

  25. 25
    Wolfgang Zimmermann, Überlebensraten älterer AML-Patienten, Im Focus Onkologie, 2013, 16, 10, 20

    CrossRef